JC
SNY icon

Jacobs & Co’s Sanofi SNY Stock Holding History

Jacobs & Co’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,305
Closed -$207K – 136
2026
Q1 		$207K Sell
4,305
-1,510
-26% -$70.4K 0.02% 124
2025
Q4 		$281K Sell
5,815
-725
-11% -$35.9K 0.03% 111
2025
Q3 		$308K Hold
6,540
– – 0.03% 109
2025
Q2 		$315K Hold
6,540
– – 0.03% 107
2025
Q1 		$362K Hold
6,540
– – 0.04% 102
2024
Q4 		$315K Hold
6,540
– – 0.03% 107
2024
Q3 		$376K Sell
6,540
-150
-2% -$8.1K 0.04% 105
2024
Q2 		$324K Sell
6,690
-225
-3% -$10.9K 0.03% 107
2024
Q1 		$336K Hold
6,915
– – 0.04% 108
2023
Q4 		$343K Hold
6,915
– – 0.04% 103
2023
Q3 		$370K Hold
6,915
– – 0.05% 101
2023
Q2 		$372K Hold
6,915
– – 0.04% 100
2023
Q1 		$376K Sell
6,915
-1,028
-13% -$50K 0.05% 101
2022
Q4 		$384K Sell
7,943
-1,387
-15% -$60.9K 0.05% 103
2022
Q3 		$354K Hold
9,330
– – 0.05% 100
2022
Q2 		$466K Sell
9,330
-1,000
-10% -$53.1K 0.06% 93
2022
Q1 		$530K Hold
10,330
– – 0.06% 93
2021
Q4 		$517K Hold
10,330
– – 0.05% 94
2021
Q3 		$498K Sell
10,330
-1,000
-9% -$50.8K 0.06% 94
2021
Q2 		$596K Hold
11,330
– – 0.07% 93
2021
Q1 		$560K Sell
11,330
-850
-7% -$40.8K 0.07% 93
2020
Q4 		$591K Sell
12,180
-450
-4% -$22.2K 0.08% 90
2020
Q3 		$633K Sell
12,630
-125
-1% -$6.43K 0.09% 87
2020
Q2 		$651K Hold
12,755
– – 0.11% 86
2020
Q1 		$557K Hold
12,755
– – 0.11% 90
2019
Q4 		$640K Buy
12,755
+900
+8% +$42.2K 0.1% 90
2019
Q3 		$549K Buy
11,855
+400
+3% +$17.3K 0.09% 96
2019
Q2 		$495K Sell
11,455
-1,000
-8% -$42.5K 0.08% 101
2019
Q1 		$551K Sell
12,455
-120
-1% -$5.14K 0.09% 102
2018
Q4 		$546K Hold
12,575
– – 0.11% 93
2018
Q3 		$561K Sell
12,575
-1,566
-11% -$66.9K 0.09% 97
2018
Q2 		$565K Sell
14,141
-1,684
-11% -$66.3K 0.1% 94
2018
Q1 		$634K Sell
15,825
-375
-2% -$15.6K 0.12% 93
2017
Q4 		$696K Sell
16,200
-25
-0.2% -$1.15K 0.13% 95
2017
Q3 		$807K Sell
16,225
-140
-0.9% -$6.77K 0.15% 94
2017
Q2 		$784K Sell
16,365
-570
-3% -$27.2K 0.15% 94
2017
Q1 		$766K Sell
16,935
-1,105
-6% -$46.9K 0.16% 95
2016
Q4 		$729K Sell
18,040
-250
-1% -$9.85K 0.16% 97
2016
Q3 		$698K Sell
18,290
-325
-2% -$13K 0.16% 93
2016
Q2 		$779K Sell
18,615
-1,210
-6% -$49.6K 0.18% 93
2016
Q1 		$796K Sell
19,825
-300
-1% -$12.1K 0.19% 96
2015
Q4 		$814K Sell
20,125
-150
-0.7% -$6.9K 0.21% 96
2015
Q3 		$962K Sell
20,275
-500
-2% -$25.5K 0.26% 90
2015
Q2 		$1.03M Hold
20,775
– – 0.26% 94
2015
Q1 		$1.03M Sell
20,775
-650
-3% -$31.1K 0.26% 90
2014
Q4 		$977K Sell
21,425
-950
-4% -$46.1K 0.26% 90
2014
Q3 		$1.26M Sell
22,375
-18
-0.1% -$967 0.36% 82
2014
Q2 		$1.19M Sell
22,393
-4,982
-18% -$264K 0.34% 82
2014
Q1 		$1.43M Buy
27,375
+1,750
+7% +$88.6K 0.44% 73
2013
Q4 		$1.37M Sell
25,625
-100
-0.4% -$5.16K 0.44% 73
2013
Q3 		$1.3M Sell
25,725
-1,200
-4% -$61.1K 0.45% 74
2013
Q2 		$1.39M Buy
+26,925
New +$1.43M 0.5% 69

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
PCM
Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return

Jacobs & Co's SNY Position: Q2 2026 in Review

Jacobs & Co sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,305 shares — an estimated $207K sold.

Jacobs & Co first reported a position in SNY in Q2 2013 and held it in 52 quarters. The position peaked at $1.43M in Q1 2014. 107 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Jacobs & Co reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Jacobs & Co sold 4,305 Sanofi shares in Q2 2026, an estimated $207K.
  • Jacobs & Co first reported a position in Sanofi in Q2 2013 and held it in 52 quarters.
  • Jacobs & Co's Sanofi position peaked at $1.43M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.